UC-II® undenatured type II collagen data show retention during functional food and beverage prototype processing.
Beverages
Foods
Functional nutrients
Joint health
Undenatured type II collagen
Journal
Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
19
01
2023
revised:
21
04
2023
accepted:
03
05
2023
medline:
29
6
2023
pubmed:
29
6
2023
entrez:
29
6
2023
Statut:
epublish
Résumé
Nowadays, collagen is widely used in food and beverage industries to enhance the nutritional and health value of the products. While many see this as an ideal way to incorporate more collagen into their diets, the exposure of these proteins to high temperature or acidic and alkaline solutions may negatively affect the quality and activity of these supplements. In general, the manufacturing of functional food and beverages often largely depends on the stability of the active ingredients during processing. The high temperatures, humidity, and low pH of processing may reduce product nutrient retention. Hence, understanding stability of collagen is of great significance and these data were gathered to determine the extent of undenatured type II collagen retention under different processing conditions. UC-II® undenatured type II collagen is a patented form of collagen derived from chicken sternum cartilage, and different food and beverage prototypes incorporating UC-II® undenatured type II collagen were produced. The content of undenatured type II collagen was compared in their pre-and post-manufacturing formats using an enzyme-linked immunosorbent assay. The undenatured type II collagen retention varied depending upon the prototype, with the highest amount of undenatured type II collagen retention occurring in nutritional bars (approximately 100%), followed by chews (98%), gummies (96%), and dairy beverages (81%). The present work also showed that recovery of the undenatured type II collagen depends on the exposure time, temperature and pH of the prototype.
Identifiants
pubmed: 37383778
doi: 10.1016/j.dib.2023.109216
pii: S2352-3409(23)00335-9
pmc: PMC10293959
doi:
Types de publication
Journal Article
Langues
eng
Pagination
109216Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors are employees of Lonza Greenwood LLC., Greenwood, SC, USA.
Références
Adv Exp Med Biol. 1999;459:23-50
pubmed: 10335367
Experientia Suppl. 1983;44:135-56
pubmed: 6357844